Gene · 49
Papers2,647
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,647
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial. | Diabetes Care | 2023 | 36657986 | PubTator, text mining | PubMed |
| Relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus. | Lupus | 2023 | 36651432 | PubTator, text mining | PubMed |
| Anti-CRISPR Discovery: Using Magnets to Find Needles in Haystacks. | J Mol Biol | 2023 | 36638909 | PubTator, text mining | PubMed |
| Comparative proteomic analysis of seminal plasma exosomes in buffalo with high and low sperm motility. | BMC Genomics | 2023 | 36624393 | PubTator, text mining | PubMed |
| Associations of hemolysis and anemia with cardiopulmonary dysfunction in an adult sickle cell disease cohort. | Clin Chim Acta | 2023 | 36623746 | PubTator, text mining | PubMed |
| Bad players in AL amyloidosis in the current era of treatment. | Expert Rev Hematol | 2023 | 36620914 | PubTator, text mining | PubMed |
| Selective Inhibition of the MK2 Pathway: Data From a Phase IIa Randomized Clinical Trial in Rheumatoid Arthritis. | ACR Open Rheumatol | 2023 | 36604812 | PubTator, text mining | PubMed |
| New approaches for long-term conservation of rooster spermatozoa. | Poult Sci | 2023 | 36599200 | PubTator, text mining | PubMed |
| Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial. | Rheumatology (Oxford) | 2023 | 36534825 | PubTator, text mining | PubMed |
| Predicting Disease Activity in Rheumatoid Arthritis With the Fibromyalgia Survey Questionnaire: Does the Severity of Fibromyalgia Symptoms Matter? | J Rheumatol | 2023 | 36521924 | PubTator, text mining | PubMed |
| Systematic Literature Review and Meta-analysis of Venous Thromboembolism Events in Systemic Lupus Erythematosus. | Rheumatol Ther | 2023 | 36471199 | PubTator, text mining | PubMed |
| A comprehensive investigation of human endogenous retroviral syncytin proteins and their receptors in men with normozoospermia and impaired semen quality. | J Assist Reprod Genet | 2023 | 36469256 | PubTator, text mining | PubMed |
| Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening. | Mol Biol Rep | 2023 | 36436079 | PubTator, text mining | PubMed |
| Molecular and pathobiological insights of bikunin/UTI in cancer. | Mol Biol Rep | 2023 | 36414878 | PubTator, text mining | PubMed |
| Early Retinal Microvasculopathy in Prediabetic Patients and Correlated Factors. | Ophthalmic Res | 2023 | 36382640 | PubTator, text mining | PubMed |
| Alternative pathway activation in pregnancy, a measured amount "complements" a successful pregnancy, too much results in adverse events. | Immunol Rev | 2023 | 36377667 | PubTator, text mining | PubMed |
| Investors' confidence in the crowdlending platform and the impact of Covid-19. | J Bus Res | 2023 | 36373084 | PubTator, text mining | PubMed |
| Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group. | Semin Arthritis Rheum | 2023 | 36372016 | PubTator, text mining | PubMed |
| 1α,25-dihydroxyvitamin D3 supplementation alleviates perfluorooctanesulfonate acid-induced reproductive injury in male mice: Modulation of Nrf2 mediated oxidative stress response. | Environ Toxicol | 2023 | 36321694 | PubTator, text mining | PubMed |
| Large 22q13.3 deletions perturb peripheral transcriptomic and metabolomic profiles in Phelan-McDermid syndrome. | HGG Adv | 2023 | 36276299 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/49/papers?page=17